The Influence of Thyroid Hormones on Levels of Lipid Profile and Adipokine in Iraqi Women with Thyroid Disorders
Keywords:
Hyperthyroidism, Hypothyroidism, Lipid profile, Retinol-binding protein-4Abstract
Hypothyroidism and hyperthyroidism are prevalent endocrine diseases. These have significant implications for lipid synthesis, mobilization, and metabolism. Retinol-binding protein 4 is a new adipokine implicated in some physiological and pathological processes, such as metabolic and endocrine disorders. Its elevation aids in the diagnosis of thyroid problems. The present study includes 60 women with thyroid diseases; 30 of them have hypothyroidism and 30 have hyperthyroidism. This study includes 20 healthy women as a control group. For each participant anthropometric, biochemical Thyroid-stimulating hormone, triiodothyronine, Thyroxine, lipid profile, and retinol binding protein-4 are measured. The results show that hypothyroid women have significantly higher levels of total cholesterol, triglycerides, and low-density lipoprotein cholesterol as compared to the hyperthyroid or control group. The serum of total cholesterol, triglycerides, and low-density lipoprotein cholesterol are significantly lower in hyperthyroid women compared to the hypothyroid or control group. In addition, there are no significant differences in blood high-density lipoprotein cholesterol concentrations among the three groups. Furthermore, serum retinol-binding protein-4 levels were higher in the hyperthyroid group compared to the hypothyroid or control groups. According to the findings of this study, hypothyroidism causes dyslipidemia, which raises the risk of cardiovascular disease while hyperthyroidism causes abnormalities in lipid profiles. Additionally, hyperthyroidism causes an increase in serum retinol-binding protein-4 levels in the blood.
References
Prabal, P.; Alfredo. I.; Elmer, J. G. A.; Nazila, E.; Sathish, B.; Michael, F.; “Thyroid ultrasound texture classification using autoregressive features in conjunction with machine learning approaches”. IEEE Access, 7: 79354–79365, 2019.
Rajani, S.; “Surgical Anatomy of Thyroid Gland A Comprehensive Review”. Basic Sci. Med. 9 (1): 10–14, 2020.
Ceyhun, B.; Ajay, P.; “Plasticizers: negative impacts on the thyroid hormone system”. Environ. Sci. Pollut. Res., 29 (26): 38912–38927, 2022.
Santanu, M.; Debasish, M.; Karuppusamy, R.; Govindasamy, M.; “Halogen bonding in biomimetic deiodination of thyroid hormones and their metabolites and dehalogenation of halogenated nucleosides”. Chem. Bio. Chem., 21(7): 911–923, 2020.
Zainab, A.M.; Shaima, R.I.; Aida, H.I.; “A correlation study between hyperthyroidism and some apoptosis markers among Iraqi patients”. Iraqi . J. Sci., 62 (5): 1484–1493, 2021.
Abeer, C.Y.A.; “An evaluation of blood glucose and lipid profile in female hypothyroidism patients in Kerbala province, Iraq”. Biomed., 42 (3): 556–560, 2022.
Waled, A.H.; Azab, E.; Laila, H.F.S.; “Correlation between Hypothyroidism, Hyperthyroidism and Lipid Profile in Thyroid Dysfunction Patients”. Clin. Med. J., 4 (2): 6–14, 2018.
Daniel, A.; Gabriela, H.; Bárbara, R.; Janette, F.; “Adipokine contribution to the pathogenesis of osteoarthritis”. Mediators Inflamm., 2017, 2017.
Pierre, S.M.; Zeina, A.; Pousette, F.H.; Syeda, S.H.; Cesar, A.P.; “Adipocytokines: Are they the Theory of Everything?”. Cytokine, 133, 2020.
Pamela, A.N.; Matthias, B.; “Retinol-binding protein 4 in obesity and metabolic dysfunctions”. Mol. Cell. Endocrinol., 531: 111312, 2021.
Thomas, O.; Rune, B.; “Retinol, Retinoic Acid, and Retinol-Binding Protein 4 are Differentially Associated with Cardiovascular Disease, Type 2 Diabetes, and Obesity: An Overview of Human Studies”. Adv. Nutr., 11(3): 644–666, 2020.
Julia, S.S.; Achim, L.; Michael, S.; “Biological functions of RBP4 and its relevance for human diseases”. Front. Physiol., 12, 659977, 2021.
Suman, T.; Nirupama, D.; Devi Prasad, P.; Rasmita, K.P.; Sucheta, P.; Sudipta, O.; “Role of Serum Retinol Binding Protein 4 (RBP4) Concentration in Patients with Primary Hypertension: A Case-control Study”. J. Clin. Diagnostic Res., 16(10): BC18-BC21, 2022.
Yanyan, C.; Xiafang, W.; Ruirui, W.; Xiance, S.; Boyi, Y.; Yi, W.; Yuanyuan, X.; “Changes in profile of lipids and adipokines in patients with newly diagnosed hypothyroidism and hyperthyroidism”. Nat. Publ. Gr., 6, 1–7, 2016.
Hussein, M.O.; Athmar, J.A.A.; Suhad, R.M.; “Comparing the Concentrations of Thyroid Stimulating Hormone and Thyroid Hormone in Females with Hypothyroidism and hyperthyroidism in Iraq''. J. Pharma. Negat. Result., 13(3): 878-880, 2022.
Payman, A.H.; Saeed, K.H.; Sana, M.A.; “Evaluation of Thyroid stimulating hormone and thyroid hormone concentrations in females with hypothyroidism and hyperthyroidism”. Rafidain J. Sci., 28(4): 1–7, 2019.
Eiman, A.A.A.; Warka’a, T.A.; Mezher, N.M.; “A comparative study of retinol-binding protein-4 and progranulin in iraqi women with thyroid disorder”. Int. J. Drug Deliv. Technol., 11(1): 36–41, 2021.
Yanqin, H.; Yue, S.; Yuxuan, H.; Qiuxia, L.; Fan, R.;"Serum Levels of CXCL-13, RBP-4, and IL-6, and Correlation Analysis of Patients with Graves’ Disease”. Emerg. Med. Int., 2022, 2022.
Yaccil, A.F.; Martha, I.B.; Juan, M.M.; Cecilia, C.G.; Eugenia F.; and Mónica, E.; “Interplay of retinol binding protein 4 with obesity and associated chronic alterations”. Mol. Med. Rep., 26 (1): 1–12, 2022.
Rashmi, M.; Yan-Yun, L.; Gregory, A.; “Thyroid hormone regulation of metabolism”. Physiol. Rev., 94, 355-382, 2014.
Divya, U.; Jean, M.; Geetha, N.; “Association of insulin resistance and lipid profile with serum T3, T4, and TSH in patients with hypothyroidism”. Natl. J. Physiol. Pharm. Pharmacol., 13(3): 499-503, 2023.
Huixing, L.; Daoquan, P.; “Update on dyslipidemia in hypothyroidism: the mechanism of dyslipidemia in hypothyroidism”. Endocr. Connect., 11(2): e210002, 2022.
Azhar, Y.D.; Abeer, A.A.A.; “Estimation of Visfatin, Adiponectin Hormone and Lipid Profile in Hyperthyroidism Patients”. Ann. Rom. Soc. Cell Biol., 25 (4): 5617–5626, 2021.
Jeongmin, L.; Jeonghoon, H.; Kwanhoon, J.; Dong-Jun, L.; Jung-Min, L.; Sang-Ah, C.; Moo-Il, C.; Min-Hee, K.; “High normal range of free thyroxine is associated with decreased triglycerides and with increased high-density lipoprotein cholesterol based on population representative data”. J. Clin. Med. 8 (6): 758, 2019.
Mahmood, S.M.; Measer, A.A.; “Effect of Hyperthyroidism on Lipid Metabolism and Evaluation of the Protective Role of Pomegranate Juice against the Risk of Oxidative Stress in Albino Rats”. Int. J. Drug Deliv. Technol., 12 (1): 373–378, 2022.
Gopalakrishnan, M.; Ramidha, P.; Vinitha,V.; “Comparative study of lipid profile anomalies in thyroid dysfunction”. Natl. J. Physiol. Pharm. Pharmacol., 12(9):1366-1370, 2022.
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Kawther Abaas, Alaa Hussein J. AL-Qaisi , Nany Hairunisa
This work is licensed under a Creative Commons Attribution 4.0 International License.
.jpg)
